← All stocks

InspireMD, Inc.

NSPR Net buying
CIK 0001433607 #4780 in the set updated 17 Sep 2026
Bought (120 mo)
$2.50M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$288.94K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$288.94K
26 of 26 sales
Net
+$2.22M
+$2.22M against sales at will

By person

16 insiders · 77 transactions
5.2×

Marvin Slosman holds 5.2 times base salary in stock. $3.11M of shares against $588.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Marvin Slosman last reported holding, valued at $0.88, the price Common Stock was last bought or sold at on the open market here, on 27 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ROUBIN GARY S
Director
$994.15K (11)
+$994.15K
834,478
1.79%
$730.17K
Stuka Paul
Director
$786.98K (20)
$11.54 (1)
+$786.97K
1,124,812
2.42%
$984.21K
Gleason Shane Thomas
Chief Commercial Officer
$288.92K (24)
−$288.92K
1,053,882
2.27%
$922.15K
Kester Thomas J
Director
$270.74K (4)
$1.68 (1)
+$270.74K
458,573
0.9864%
$401.25K
BERMAN MICHAEL
Director
$250.00K (2)
+$250.00K
597,580
1.29%
$522.88K
Ward Scott R.
Director
$102.64K (2)
+$102.64K
237,096
0.5100%
$207.46K
+444.4%
Slosman Marvin
CEO and President
$100.19K (4)
+$100.19K
3,556,658
7.65%
$3.11M
Barry James J
President and CEO
2,166,382
4.66%
$1.90M
+8,798%
Shore Craig
CFO and CAO
1,112,460
2.39%
$973.40K
Tommasoli Andrea
Chief Operating Officer
954,389
2.05%
$835.09K
+1,133%
Lawless Michael A
Chief Financial Officer
691,695
1.49%
$605.23K
+48.8%
Verta Patrick
EVP Clinical/Medical Affairs
311,532
0.6701%
$272.59K
+118.3%
Arnold Kathryn
Director
303,087
0.6520%
$265.20K
Dearen Danny L.
Director
102,047
0.2195%
$89.29K
+75.9%
COHEN RAYMOND W
Director
92,417
0.1988%
$80.86K
+91.0%
Rogers Campbell
Director
27,960
0.0601%
$24.47K
Insider
Date
Role
Action
Shares
Price
Amount
Gleason Shane Thomas
19 May 2026
Chief Commercial Officer
Sell
22,778
$1.01
$23.01K
Gleason Shane Thomas
2 Feb 2026
Chief Commercial Officer
Sell
2,000
$1.60
$3.21K
Gleason Shane Thomas
2 Feb 2026
Chief Commercial Officer
Sell
2,941
$1.59
$4.68K
Gleason Shane Thomas
30 Jan 2026
Chief Commercial Officer
Sell
2,900
$1.63
$4.73K
Gleason Shane Thomas
29 Jan 2026
Chief Commercial Officer
Sell
5,000
$1.65
$8.25K
Gleason Shane Thomas
28 Jan 2026
Chief Commercial Officer
Sell
12,395
$1.65
$20.46K
Gleason Shane Thomas
27 Jan 2026
Chief Commercial Officer
Sell
4,781
$1.66
$7.96K
Gleason Shane Thomas
22 Jan 2026
Chief Commercial Officer
Sell
8,411
$1.57
$13.24K
Gleason Shane Thomas
21 Jan 2026
Chief Commercial Officer
Sell
17,593
$1.62
$28.55K
Gleason Shane Thomas
20 Jan 2026
Chief Commercial Officer
Sell
2,955
$1.59
$4.71K
Gleason Shane Thomas
16 Jan 2026
Chief Commercial Officer
Sell
2,250
$1.61
$3.63K
Gleason Shane Thomas
15 Jan 2026
Chief Commercial Officer
Sell
2,909
$1.58
$4.59K
Gleason Shane Thomas
30 May 2025
Chief Commercial Officer
Sell
7,186
$2.51
$18.04K
Gleason Shane Thomas
29 May 2025
Chief Commercial Officer
Sell
3,760
$2.51
$9.44K
Gleason Shane Thomas
27 May 2025
Chief Commercial Officer
Sell
1,572
$2.51
$3.95K
Gleason Shane Thomas
23 May 2025
Chief Commercial Officer
Sell
2,482
$2.51
$6.23K
Gleason Shane Thomas
25 Feb 2025
Chief Commercial Officer
Sell
10,000
$3.65
$36.50K
Gleason Shane Thomas
4 Feb 2025
Chief Commercial Officer
Sell
5,132
$2.46
$12.62K
Gleason Shane Thomas
3 Feb 2025
Chief Commercial Officer
Sell
7,073
$2.51
$17.75K
Gleason Shane Thomas
31 Jan 2025
Chief Commercial Officer
Sell
9,923
$2.55
$25.30K
Gleason Shane Thomas
30 Jan 2025
Chief Commercial Officer
Sell
2,454
$2.51
$6.16K
Gleason Shane Thomas
29 Jan 2025
Chief Commercial Officer
Sell
3,660
$2.46
$9.00K
Gleason Shane Thomas
28 Jan 2025
Chief Commercial Officer
Sell
2,476
$2.61
$6.46K
Gleason Shane Thomas
27 Jan 2025
Chief Commercial Officer
Sell
3,858
$2.71
$10.46K
Stuka Paul
11 Dec 2018
Director
Sell indirect
65
$0.18
$11.54
Kester Thomas J
21 Nov 2018
Director
Sell
8
$0.21
$1.68

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 15,200,772
Sales filed before the plan box existed 2
History held since 8 Sep 2016